Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- PCI DSS therapy for the smaller retailer (McAfee)
- Recognizing the benefits of telework (Citrix Online)
First generic metronidazole vaginal gel
FDA Consumer, Jan-Feb, 2007
The FDA has approved the first generic version of MetroGel-Vaginal (metronidazole vaginal gel), a treatment for bacterial vaginosis.
Bacterial vaginosis is a condition in women that is characterized by vaginal discharge and results from an overgrowth of bacteria in the vagina.
"Metronidazole vaginal gel is a widely-used antibacterial preparation, and its generic version can bring significant savings to the millions of Americans with bacterial vaginosis," said Gary J. Buehler, director of the FDA's Office of Generic Drugs, after the drug's approval in November 2006.
Metronidazole Vaginal Gel, 0.75%, is manufactured by QLT USA Inc. in Fort Collins, Colo.
COPYRIGHT 2007 U.S. Government Printing Office
COPYRIGHT 2007 Gale Group